The hypoxia response pathway and β-cell function

Diabetes, Obesity and Metabolism

Volumn 12, Issue SUPPL. 2, 2010, Pages 159-167

  Cantley, J ^a,b   Grey, S T ^b,c   Maxwell, P H ^a   Withers, D J ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c Australian Islet Transplant Consortium   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Atmosphere; Glucose stimulated insulin secretion; Hypoxia response element; Reactive oxygen species

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; MONOCARBOXYLATE TRANSPORTER 4; PLATELET DERIVED GROWTH FACTOR; PYRUVATE DEHYDROGENASE KINASE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ANAEROBIC GLYCOLYSIS; ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL HYPOXIA; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HYPOXIA; INSULIN RELEASE; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL TUMOR; PANCREAS ISLET TRANSPLANTATION; PATHOGENESIS; PATHOGENICITY; PROTEIN DEGRADATION; VASCULARIZATION;

EID: 77957311262     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01276.x     Document Type: Article

References (70)

1. Canfield DE, Poulton SW, Narbonne GM. Late-neoproterozoic deep-ocean oxygenation and the rise of animal life. Science 2007, 315:92-95..
2. Mason SD, Howlett RA, Kim MJ. Loss of skeletal muscle HIF-1alpha results in altered exercise endurance. PLoS Biol 2004, 2:e288..
3. Mason SD, Rundqvist H, Papandreou I. HIF-1{alpha} in endurance training: suppression of oxidative metabolism. Am J Physiol Regul Integr Comp Physiol 2007, 293:R2059-R2069..
4. Aragones J, Schneider M, Van Geyte K. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 2008, 40:170-180..
5. Zhong L, D'Urso A, Toiber D. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010, 140:280-293..
6. Park SK, Haase VH, Johnson RS. von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase. Int J Oncol 2007, 30:341-348..
7. Wang XL, Suzuki R, Lee K. Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones. Cell Metab 2009, 9:428-439..
8. Halberg N, Khan T, Trujillo ME. HIF 1 alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009, 29:4467-4483..
9. Cantley J, Selman C, Shukla D. Deletion of the von Hippel-Lindau gene in pancreatic β cells impairs glucose homeostasis in mice. J Clin Invest 2009, 119:125-135. doi:10.1172/JCI26934.
10. Puri S, Cano D, Hebrok M. A role for Von-Hippel Lindau protein in pancreatic β-cell function. Diabetes 2008, 58:433-441..
11. Zehetner J, Danzer C, Collins S. PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells. Genes Dev 2008, 22:3135-3146..
12. Gunton JE, Kulkarni RN, Yim S. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 122:337-349..
13. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 2008, 8:851-864..
14. Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell 2006, 21:521-531..
15. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12:5447-5454..
16. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005, re12.. Oct 18; (306):
17. Lendahl U, Lee KL, Yang H, Poellinger L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet 2009, 10:821-832..
18. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995, 92:5510-5514..
19. Sogawa K, Nakano R, Kobayashi A. Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation. Proc Natl Acad Sci USA 1995, 92:1936-1940..
20. Antonsson C, Arulampalam V, Whitelaw ML, Pettersson S, Poellinger L. Constitutive function of the basic helix-loop-helix/PAS factor Arnt. Regulation of target promoters via the E box motif. J Biol Chem 1995, 270:13968-13972..
21. Jaakkola P, Mole DR, Tian YM. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472..
22. Maxwell PH, Wiesener MS, Chang GW. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275..
23. Frew IJ, Krek W. pVHL: a multipurpose adaptor protein. Sci Signal 2008, 1:pe30..
24. Ward JP. Oxygen sensors in context. Biochim Biophys Acta 2008, 1777:1-14..
25. Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001, 50:1-11..
26. Schuit F, De Vos A, Farfari S. Metabolic fate of glucose in purified islet cells. J Biol Chem 1997, 272:18572-18579..
27. Quintens R, Hendrickx N, Lemaire K, Schuit F. Why expression of some genes is disallowed in beta-cells. Biochem Soc Trans 2008, 36:300-305..
28. Gribble FM. Intolerant of glucose and gasping for oxygen. Nat Med 2009, 15:247-249..
29. Ainscow EK, Zhao C, Rutter GA. Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes 2000, 49:1149-1155..
30. Nicholls LI, Ainscow EK, Rutter GA. Glucose-stimulated insulin secretion does not require activation of pyruvate dehydrogenase: impact of adenovirus-mediated overexpression of PDH kinase and PDH phosphate phosphatase in pancreatic islets. Biochem Biophys Res Commun 2002, 291:1081-1088..
31. Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 2007, 19:223-229..
32. Heinis M, Simon M-T, Ilc K. Oxygen tension regulates pancreatic β-cell differentiation through hypoxia-inducible factor 1α. Diabetes 2010, 59:662-669..
33. Kaelin WG. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun 2005, 338:627-638..
34. Rankin EB, Rha J, Unger TL. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 2008, 27:5354-5358..
35. Iturrioz X, Durgan J, Calleja V. The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase C delta. Biochem J 2006, 397:109-120..
36. Okuda H, Saitoh K, Hirai S. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem 2001, 276:43611-43617..
37. Dunwoodie SL. The role of hypoxia in development of the mammalian embryo. Dev Cell 2009, 17:755-773..
38. Gustafsson MV, Zheng X, Pereira T. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005, 9:617-628..
39. Coleman ML, McDonough MA, Hewitson KS. Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J Biol Chem 2007, 282:24027-24038..
40. Kaelin WG, Iliopoulos O, Lonergan KM, Ohh M. Functions of the von Hippel-Lindau tumour suppressor protein. J Intern Med 1998, 243:535-539..
41. Woodward ER, Maher ER. Von Hippel-Lindau disease and endocrine tumour susceptibility. Endocr Relat Cancer 2006, 13:415-425..
42. Raval RR, Lau KW, Tran MG. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005, 25:5675-5686..
43. Shen HCJ, Adem A, Ylaya K. Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations. PLoS One 2009, 4:e4897..
44. Gnarra JR, Ward JM, Porter FD. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 1997, 94:9102-9107..
45. Haase VH, Glickman JN, Socolovsky M, Jaenisch R. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 2001, 98:1583-1588..
46. Heiser PW, Lau J, Taketo MM, Herrera PL, Hebrok M. Stabilization of β-catenin impacts pancreas growth. Development 2006, 133:2023-2032..
47. Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 2001, 50:489-495..
48. Rooth P, Dawidson I, Lafferty K. Prevention of detrimental effect of cyclosporin A on vascular ingrowth of transplanted pancreatic islets with verapamil. Diabetes 1989, 38(Suppl. 1):202-205..
49. Lammert E, Gu G, McLaughlin M. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2003, 13:1070-1074..
50. Miao G, Ostrowski RP, Mace J. Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Am J Transpl 2006, 6:2636-2643..
51. Juang JH, Hsu BR, Kuo CH, Uengt SW. Beneficial effects of hyperbaric oxygen therapy on islet transplantation. Cell Transpl 2002, 11:95-101..
52. Lehmann R, Zuellig RA, Kugelmeier P. Superiority of small islets in human islet transplantation. Diabetes 2007, 56:594-603..
53. Marselli L, Thorne J, Ahn YB. Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 2008, 93:1046-1053..
54. Weir GC, Bonner-Weir S. A dominant role for glucose in beta cell compensation of insulin resistance. J Clin Invest 2007, 117:81-83..
55. Li X, Zhang L, Meshinchi S. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes 2006, 55:2965-2973..
56. Hosogai N, Fukuhara A, Oshima K. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911..
57. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007, 293:E1118-E1128..
58. Pasarica M, Sereda OR, Redman LM. Reduced adipose tissue oxygenation in human obesity. Diabetes 2009, 58:718-725..
59. Wang W, Upshaw L, Strong DM, Robertson RP, Reems J. Increased oxygen consumption rates in response to high glucose detected by a novel oxygen biosensor system in non-human primate and human islets. J Endocrinol 2005, 185:445-455..
60. Jonas JC, Bensellam M, Duprez J, Elouil H, Guiot Y, Pascal SM. Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes. Diabetes Obes Metab 2009, 11(Suppl. 4):65-81..
61. Muraki I, Tanigawa T, Yamagishi K. Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS). Diabetologia 2010, 53:481-488..
62. Guzy RD, Hoyos B, Robin E. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metabolism 2005, 1:401-408..
63. Brunelle JK, Bell EL, Quesada NM. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005, 1:409-414..
64. Mansfield KD, Guzy RD, Pan Y. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-[alpha] activation. Cell Metab 2005, 1:393-399..
65. Kaelin WG. ROS: really involved in oxygen sensing. Cell Metab 2005, 1:357-358..
66. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004, 279:42351-42354..
67. Park Y-K, Ahn D-R, Oh M. Nitric oxide donor, ({+/-})-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1{alpha} by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation. Mol Pharmacol 2008, 74:236-245..
68. Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J 2003, 370:1011-1017..
69. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003, 17:2115-2117..
70. Sandler S, Andersson A, Hellerstrom C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987, 121:1424-1431..